Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial

被引：44

作者：

Zhao, Jing ^{[1
]}

Tostivint, Isabelle ^{[2
,3
]}

Xu, Lingdong ^{[1
]}

Huang, Jihan ^{[4
]}

Gambotti, Laetitia ^{[5
]}

Boffa, Jean-Jacques ^{[3
,6
]}

Yang, Min ^{[7
]}

Wang, Ling ^{[8
]}

Sun, Zhuxing ^{[9
]}

Chen, Xiaolan ^{[10
]}

Liou-Schischmanoff, Amelie ^{[3
,11
]}

Baumelou, Alain ^{[2
,3
]}

Ma, Teng ^{[12
]}

Lu, Guoyuan ^{[13
]}

Li, Ling ^{[14
]}

Chen, Dai ^{[15
]}

Pieroni, Laurence ^{[16
]}

Liu, Bingkai ^{[3
]}

Qin, Xiao ^{[1
]}

He, Weiming ^{[1
]}

Wang, Yuejuan ^{[1
]}

Gu, Harvest F. ^{[17
]}

Sun, Wei ^{[1
]}

机构：

[1] Nanjing Univ Chinese Med, Dept Nephrol, Affiliated Hosp, Nanjing, Peoples R China

[2] Sorbonne Univ, Pitie Salpetriere Hosp, Dept Nephrol, Paris, France

[3] Sorbonne Univ, Pitie Salpetriere Hosp, Ctr Integrat Chinese Med, Paris, France

[4] Shanghai Univ Tradit Chinese Med, Ctr Drug Clin Res, Shanghai, Peoples R China

[5] Natl Canc Inst, Dept Clin Res, Boulogne, France

[6] Sorbonne Univ, Hosp Tenon, Dept Nephrol, Paris, France

[7] First Peoples Hosp Changzhou, Dept Nephrol, Changzhou, Peoples R China

[8] First Peoples Hosp Xuzhou, Dept Nephrol, Xuzhou, Peoples R China

[9] Wuxi Peoples Hosp, Dept Nephrol, Wuxi, Jiangsu, Peoples R China

[10] Nantong Univ, Dept Nephrol, Affiliated Hosp, Nantong, Peoples R China

[11] Sorbonne Univ, Dept Pharm, Pitie Salpetriere, Paris, France

[12] Taizhou Hosp Tradit Chinese Med, Dept Nephrol, Taizhou, Peoples R China

[13] Soochow Univ, Dept Nephrol, Affiliated Hosp 1, Suzhou, Peoples R China

[14] Southeast Univ, Zhongda Hosp, Dept Endocrinol, Nanjing, Peoples R China

[15] Changzhou Hosp Tradit Chinese Med, Dept Nephrol, Changzhou, Peoples R China

[16] Sorbonne Univ, Hosp Tenon, Dept Biochem Hormonol, Paris, France

[17] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Nanjing, Peoples R China

来源：

DIABETES CARE | 2022年 / 45卷 / 07期

关键词：

NEPHROPATHY;

D O I：

10.2337/dc22-0607

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：E113 / E115

页数：3

共 50 条

[31] Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial
Tatovic, Danijela
Marwaha, Ashish
Taylor, Peter
Hanna, Stephanie J.
Carter, Kym
Cheung, W. Y.
Luzio, Steve
Dunseath, Gareth
Hutchings, Hayley A.
Holland, Gail
Hiles, Steve
Fegan, Greg
Williams, Evangelia
Yang, Jennie H. M.
Domingo-Vila, Clara
Pollock, Emily
Wadud, Muntaha
Ward-Hartstonge, Kirsten
Marques-Jones, Susie
Bowen-Morris, Jane
Stenson, Rachel
Levings, Megan K.
Gregory, John W.
Tree, Timothy I. M.
Dayan, Colin
USTEKID Study Gp, Evelien
NATURE MEDICINE, 2024, 30 (09) : 2657 - 2666
[32] Ineffectiveness of allopurinol in reduction of oxidative stress in diabetic patients; a randomized, double-blind placebo-controlled clinical trial
Afshari, M
Larijani, B
Rezaie, A
Mojtahedi, A
Zamani, MJ
Astanehi-Asghari, F
Mostafalou, S
Hossein-nezhad, A
Heshmat, R
Abdollahi, M
BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (10) : 546 - 550
[33] Telmisartan combined with probucol effectively reduces urinary protein in patients with type 2 diabetes: A randomized double-blind placebo-controlled multicenter clinical study
Zhu, Hanyu
Chen, Xiangmei
Cai, Guangyan
Zheng, Ying
Liu, Moyan
Liu, Wenhu
Yao, Hebin
Wang, Yaping
Li, Wenge
Wu, Hua
Lun, Lide
Zhang, Jianrong
Guan, Xiaohong
Yin, Shinan
Zhuang, Xiaoming
Li, Jijun
Liu, Yanjun
Zhou, Chunhua
JOURNAL OF DIABETES, 2016, 8 (05) : 677 - 685
[34] Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: A randomized, double-blind, active parallel-controlled, multicenter clinical trial
Li, Huafang
Luo, Jianfeng
Wang, Chuanyue
Xie, Shiping
Xu, Xiufeng
Wang, Xiaoping
Yu, Wenjuan
Gu, Niufan
Kane, John M.
SCHIZOPHRENIA RESEARCH, 2014, 157 (1-3) : 112 - 119
[35] Exenatide and Renal Outcomes in Patients with Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter, Randomized, Parallel Study
Wang, Xiangyu
Zhang, Qian
Guan, Meiping
Sheng, Shuyue
Mo, Wei
Zou, Mengchen
Li, Jimin
Bi, Jianlu
Tang, Xianyu
He, Jiali
Xu, Gugen
Li, Ping
Zhang, Huijie
Xue, Yaoming
DIABETES, 2020, 69
[36] Effect of canagliflozin in non-diabetic obese patients with albuminuria: A randomized, double-blind, placebo-controlled trial
Greeviroj, Primploy
Puapatanakul, Pongpratch
Phannajit, Jeerath
Takkavatakarn, Kullaya
Kittanamongkolchai, Wonngarm
Boonchaya-Anant, Patchaya
Katavetin, Pisut
Praditpornsilpa, Kearkiat
Eiam-Ong, Somchai
Susantitaphong, Paweena
CLINICAL NEPHROLOGY, 2023, 100 (05) : 224 - 230
[37] A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ANAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES
Yang, H. K.
Lee, S. H.
Min, K. W.
Park, S. W.
Chung, C. H.
Park, K. S.
Choi, S. H.
Song, K. -H.
Kim, D. -M.
Lee, M. -K.
Sung, Y. A.
Baik, S. H.
Kim, I. J.
Cha, B. -S.
Park, J. H.
Ahn, Y. B.
Lee, I. -K.
Yoo, S. -J.
Kim, J. T.
Park, I. B.
Park, T. S.
Yoon, K. -H.
DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S149 - S150
[38] THE EFFICACY AND SAFETY OF IMARIKIREN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND MICROALBUMINURIA: A RANDOMIZED, MULTI CENTER, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL
Ito, Sadayoshi
Kagawa, Tomoya
Umeda, Yuusuke
Sano, Yuhei
Shimizu, Kohei
Kuroda, Shingo
Saiki, Takuya
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
[39] Efficacy and safety of linagliptin plus insulin in Chinese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial
Yang, Wenying
Shen, Jie
Ye, Binqi
Qi, Sheng
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35
[40] Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial
Ji, Linong
Lu, Jinmiao
Gao, Leili
Ying, Changjiang
Sun, Jiao
Han, Jie
Zhao, Wenhua
Gao, Yunming
Wang, Kun
Zheng, Xin
Xie, Daosheng
Ding, Juping
Zhao, Jiahong
Yu, Qiang
Wang, Tong
DIABETES OBESITY & METABOLISM, 2023, 25 (12): : 3671 - 3681

← 1 2 3 4 5 →